Clinical Trial: Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07237425) titled 'Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma' on Nov. 13.

Brief Summary: This study aims to evaluate the safety, efficacy, and pharmacokinetics of Ronkyla Plus, a combinational drug that forms a hydrogel at the injection site, promising a better experience of lipolysis injection for the treatment of superficial lipoma. The study consists of a Part I dose-escalation study to investigate the drug's maximum tolerated dose (MTD) for this indication and a Part II study for evaluating its relative bioavailability in comparison to an FDA-approved lipolysis injection, Kybella.

Study Start Date: Nov. 14

Stud...